After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is presenting enhanced drug deposition results compared to classic nasal sprays with RetroNose.
And get access to unlimited world-class packaging reporting and commentary.